OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies
Andrey Rubanov, Pietro Berico, Eva Hernando
Cancers (2022) Vol. 14, Iss. 23, pp. 5858-5858
Open Access | Times Cited: 10

Showing 10 citing articles:

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
Giorgia Castellani, Mariachiara Buccarelli, Maria Beatrice Arasi, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4026-4026
Open Access | Times Cited: 68

Phytoflavonoids as alternative therapeutic effect for melanoma: Integrative Network pharmacology, molecular dynamics and drug-likeness profiling for lead discovery
Manoj Kumar Prajapati, Abhilasha Mittal, Pritipadma Panda
Computational Biology and Chemistry (2025) Vol. 117, pp. 108390-108390
Closed Access

Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability
Pietro Berico, Maguelone Nogaret, Max Cigrang, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113363-113363
Open Access | Times Cited: 9

Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies
PatrĂ­zia Limonta, Raffaella Chiaramonte, Lavinia Casati
Cancers (2024) Vol. 16, Iss. 16, pp. 2861-2861
Open Access | Times Cited: 2

Novel synthetic ecteinascidins exhibit potent anti-melanoma activity by suppressing super-enhancer-driven oncogenic transcription
Max Cigrang, Julian Obid, Maguelone Nogaret, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Chitosan/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo/immuno-resistance in unresectable metastatic melanoma
Qi Tang, Shaolong Leng, Yinqiu Tan, et al.
Carbohydrate Polymers (2024) Vol. 346, pp. 122645-122645
Closed Access | Times Cited: 1

Epigenetics of Conjunctival Melanoma: Current Knowledge and Future Directions
Karin Flick, Hakan Demirci, F. Yesim Demirci
Cancers (2024) Vol. 16, Iss. 21, pp. 3687-3687
Open Access | Times Cited: 1

Exploring STK3 in melanoma: a systematic review of signaling networks and therapeutic opportunities
Maryam Khanahmadi, Mohsen Ebrahimi Fard, Matin Baghani, et al.
Molecular Biology Reports (2024) Vol. 52, Iss. 1
Closed Access | Times Cited: 1

Page 1

Scroll to top